Claims-Derived Care Gaps
Rule-driven detection of diagnostic, referral, testing, and treatment gaps. Each finding includes a severity, suggested intervention, and claim-trace evidence.
Critical findings
3,378
Diagnostic misses
2,985
Referral leakage
207
Testing + treatment gaps
4,734
Detected gaps
22 rules · click a row for evidence
| Severity | Category | Care gap | HCP involved | Patients | % cohort | Median delay | |
|---|---|---|---|---|---|---|---|
| Critical | Testing gap | No KIT D816V test on record | Hematology/Oncology, Pathology | 1,056 | 52.8% | 266d | View → |
| Critical | Treatment gap | Recurrent anaphylaxis without epinephrine prescription | Allergy/Immunology, ED, Pharmacy | 755 | 37.8% | - | View → |
| Critical | Diagnostic miss | Elevated tryptase without hematology referral | PCP, Allergy/Immunology | 666 | 33.3% | 90d | View → |
| Critical | Testing gap | No serum tryptase test on record | PCP, Allergy/Immunology, Hematology | 575 | 28.8% | 259d | View → |
| Critical | Diagnostic miss | Recurrent anaphylaxis without tryptase testing | Allergy/Immunology, ED | 306 | 15.3% | 172d | View → |
| Critical | Treatment gap | AdvSM patient without TKI claim | Hematology/Oncology, Pharmacy | 20 | 1% | 709d | View → |
| High | Diagnostic miss | Multiple ED visits before SM diagnosis | Emergency medicine | 1,239 | 62% | 238d | View → |
| High | Treatment gap | Therapy discontinuation without replacement | Hematology/Oncology, Pharmacy | 942 | 47.1% | 120d | View → |
| High | Testing gap | No bone marrow biopsy after suspicious pattern | Hematology/Oncology, Pathology | 708 | 35.4% | 120d | View → |
| High | Diagnostic miss | Flushing / urticaria pigmentosa without mast cell workup | Dermatology, PCP | 282 | 14.1% | 143d | View → |
| High | Treatment gap | Progression without therapy escalation | Hematology/Oncology | 119 | 6% | 90d | View → |
| High | Testing gap | No CBC differential in suspected advanced disease | Hematology/Oncology | 110 | 5.5% | 90d | View → |
| High | Referral leakage | Allergy/Immunology repeat visits without hematology referral | Allergy/Immunology | 106 | 5.3% | 60d | View → |
| High | Referral leakage | Dermatology UP without mast cell workup | Dermatology | 43 | 2.2% | 150d | View → |
| High | Diagnostic miss | GI symptoms repeatedly coded as IBS without tryptase or KIT | Gastroenterology | 26 | 1.3% | 274d | View → |
| Moderate | Diagnostic miss | Long delay between symptom proxy and SM diagnosis | All specialties | 317 | 15.9% | 823d | View → |
| Moderate | Testing gap | No DEXA despite bone pain or osteoporosis signal | PCP, Rheumatology, Endocrinology | 305 | 15.3% | 180d | View → |
| Moderate | Diagnostic miss | Bone pain / osteoporosis without SM evaluation | Rheumatology, Orthopedics, PCP | 149 | 7.5% | 229d | View → |
| Moderate | Treatment gap | High-burden ISM without symptom-directed therapy | Allergy/Immunology, Hematology | 144 | 7.2% | 653d | View → |
| Moderate | Referral leakage | Primary care repeat coding without escalation | Primary care | 41 | 2.1% | 870d | View → |
| Moderate | Referral leakage | Rheum/Ortho bone pain without mast cell evaluation | Rheumatology, Orthopedics | 14 | 0.7% | 240d | View → |
| Moderate | Referral leakage | GI pathway >24 months without tryptase | Gastroenterology | 3 | 0.2% | 1054d | View → |